[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA200705769B - Oligomeric peptides and their use for the treatment of HIV infections - Google Patents

Oligomeric peptides and their use for the treatment of HIV infections

Info

Publication number
ZA200705769B
ZA200705769B ZA200705769A ZA200705769A ZA200705769B ZA 200705769 B ZA200705769 B ZA 200705769B ZA 200705769 A ZA200705769 A ZA 200705769A ZA 200705769 A ZA200705769 A ZA 200705769A ZA 200705769 B ZA200705769 B ZA 200705769B
Authority
ZA
South Africa
Prior art keywords
treatment
hiv infections
oligomeric peptides
oligomeric
peptides
Prior art date
Application number
ZA200705769A
Other languages
English (en)
Inventor
Adermann Knut
Kirchhoff Frank
Muench Jan
Schulz Axel
Forssmann Wolf-Georg
Original Assignee
Ipf Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipf Pharmaceuticals Gmbh filed Critical Ipf Pharmaceuticals Gmbh
Publication of ZA200705769B publication Critical patent/ZA200705769B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA200705769A 2004-06-18 2005-06-17 Oligomeric peptides and their use for the treatment of HIV infections ZA200705769B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04014304 2004-06-18

Publications (1)

Publication Number Publication Date
ZA200705769B true ZA200705769B (en) 2008-09-25

Family

ID=34925397

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200705769A ZA200705769B (en) 2004-06-18 2005-06-17 Oligomeric peptides and their use for the treatment of HIV infections

Country Status (13)

Country Link
US (1) US20070123465A1 (xx)
EP (1) EP1756160B1 (xx)
JP (1) JP4782782B2 (xx)
CN (1) CN100577686C (xx)
AP (1) AP2081A (xx)
AU (1) AU2005254736B2 (xx)
BR (1) BRPI0511005A (xx)
CA (1) CA2569807A1 (xx)
EA (1) EA011037B1 (xx)
MX (1) MXPA06014393A (xx)
NO (1) NO20070296L (xx)
WO (1) WO2005123771A2 (xx)
ZA (1) ZA200705769B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103965300A (zh) * 2005-11-02 2014-08-06 Ambrx公司 生物合成多肽融合抑制剂
US9212205B2 (en) * 2007-07-26 2015-12-15 University Of Rochester Nucleic acid binding compounds and methods of use
CN101993485B (zh) * 2009-08-20 2013-04-17 重庆富进生物医药有限公司 促胰岛素分泌肽类似物同源二聚体及其用途
GR1007010B (el) * 2009-10-08 2010-10-07 Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), Ινσουλινοειδη πεπτιδια
CA2790343A1 (en) * 2010-02-18 2011-08-25 Advanced Proteome Therapeutics Inc. Site-specific modification of proteins through chemical modification enabling protein conjugates, protein dimer formation, and stapled peptides
WO2011110049A1 (zh) * 2010-03-12 2011-09-15 中国人民解放军军事医学科学院毒物药物研究所 抗hiv的融合多肽及其用途
WO2011127624A1 (zh) * 2010-04-13 2011-10-20 中国人民解放军军事医学科学院毒物药物研究所 抗hiv肽
CN102180951B (zh) * 2011-05-03 2012-09-26 中国医学科学院病原生物学研究所 胆固醇修饰的抗hiv多肽药物及其用途
US9545449B2 (en) 2012-05-11 2017-01-17 Advanced Proteone Therapeutics Inc. Site-specific labeling and targeted delivery of proteins for the treatment of cancer
CN105530948B (zh) * 2013-06-12 2023-05-26 法瑞斯生物技术有限公司 对天然cxcr4具有拮抗活性的肽
CN109922818B (zh) * 2016-09-06 2024-02-20 主线生物科学公司 Cxcr4拮抗剂及使用方法
US20190315816A1 (en) * 2016-11-09 2019-10-17 Pharis Biotec Gmbh Protransducine-c: gene transfer activator
US20220362397A1 (en) * 2019-09-26 2022-11-17 Nof Corporation Heterobifunctional monodispersed polyethylene glycol having peptide linker
JPWO2022202785A1 (xx) * 2021-03-22 2022-09-29
WO2024197259A1 (en) * 2023-03-23 2024-09-26 Brandeis University Transcytotic intercellular gelation enables cell spheroids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1228203T3 (da) * 1999-11-08 2008-10-20 Ipf Pharmaceuticals Gmbh Peptid (VIRIP), som inhiberer en cirkulerende virus i mennesker samt anvendelse deraf
EP1572743B1 (en) * 2002-12-19 2011-08-10 IPF Pharmaceuticals GmbH Peptides and their use for the treatment of hiv infections

Also Published As

Publication number Publication date
EP1756160A2 (en) 2007-02-28
WO2005123771A2 (en) 2005-12-29
EP1756160B1 (en) 2013-08-14
AP2007003877A0 (en) 2007-02-28
JP4782782B2 (ja) 2011-09-28
JP2008505854A (ja) 2008-02-28
CN1968964A (zh) 2007-05-23
CN100577686C (zh) 2010-01-06
MXPA06014393A (es) 2007-07-04
EA011037B1 (ru) 2008-12-30
AP2081A (en) 2010-01-04
AU2005254736A1 (en) 2005-12-29
BRPI0511005A (pt) 2007-11-20
CA2569807A1 (en) 2005-12-29
US20070123465A1 (en) 2007-05-31
AU2005254736B2 (en) 2011-08-18
EA200700062A1 (ru) 2007-04-27
WO2005123771A3 (en) 2006-02-09
NO20070296L (no) 2007-02-27

Similar Documents

Publication Publication Date Title
AP2007004095A0 (en) Cxcr4 antagonists for the treatment of hiv infection
IL192373A (en) Arginine cyclic peptides and their use in the treatment of fungal infections
MX287124B (en) Dual stage ultrafilter devices in the form of portable filter devices, shower devices, and hydration packs
AU2003231866A8 (en) Herbs and herbal combinations useful for the treatment of microbial infections
PL376454A1 (en) 1-acyl-pyrrolidine derivatives for the treatment of viral infections
ZA200706254B (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
AP2081A (en) Oligomeric peptides and their use for the treatment of HIV infections
EP1753777A4 (en) METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING HIV INFECTION WITH TRIM5a
PL1896502T3 (pl) Leczenie infekcji grzybowych i/lub protista
GB2411354B (en) Use of Scutellaria for the treatment of viral infections
HK1103961A1 (en) Medicament for the treatment of fungal infections, particularly aspergillosis
EP1814567A4 (en) USE OF MODULATORS OF EPHA2 AND EPHRINA1 FOR TREATING AND PREVENTING INFECTIONS
AU2003291886A1 (en) Thiophenederivatives for the treatment of flavivirus infections
ITMI20042007A1 (it) "modulatori del ricettore gpr17 e loro impieghi terapeutici"
EP1805210A4 (en) NOVEL PEPTIDES AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
EP2097090A4 (en) PEPTIDE AND TREATMENT FOR HIV-1 INFECTION
AU2003258983A8 (en) Combinations for the treatment of fungal infections
GB0300078D0 (en) Composition for the treatment of HIV and AIDS
AU2002310922A1 (en) Interferons in the treatment of ischemia
EP1813671A4 (en) SOLUBLE PROTEIN AND USE THEREOF
GB0308603D0 (en) Pharmaceutical combinations for treating viral infections
GB0522200D0 (en) Methyl- -orcinolcarboxylate from lichen (everniasrum cirrhatum) for use for the treatment of fungal infections and cancer
AU2003255866A8 (en) Gp41 epitope and uses thereof for the treatment of hiv infections
GB0308604D0 (en) Pharmaceutical combinations for treating viral infections
HK1106144A1 (en) Peptides for the treatment of herpes virus infections